Labajo, Kyle Charmaine .
HRN: 23-93-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2024
METRONIDAZOLE 500MG (TAB)
01/03/2024
01/09/2024
PO
1tab
TID
Thickly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes